# Low-Dose Taxotere® (Docetaxel) With Concurrent Radiotherapy For Localized, Inoperable Carcinoma Of The Uterine Cervix

> **NCT00178269** · PHASE2 · COMPLETED · sponsor: **University of Rochester**

## Conditions studied

- Cervix Neoplasm

## Interventions

- **DRUG:** docetaxel
- **PROCEDURE:** Radiation Therapy

## Key facts

- **NCT ID:** NCT00178269
- **Lead sponsor:** University of Rochester
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** 2006-06
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2009-05-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00178269

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00178269, "Low-Dose Taxotere® (Docetaxel) With Concurrent Radiotherapy For Localized, Inoperable Carcinoma Of The Uterine Cervix". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00178269. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*